Geron Corporation (GERN): Price and Financial Metrics

Geron Corporation (GERN): $2.56

0.23 (-8.24%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

F

Add GERN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#209 of 337

in industry

GERN Price/Volume Stats

Current price $2.56 52-week high $5.34
Prev. close $2.79 52-week low $1.64
Day low $2.52 Volume 23,221,900
Day high $2.84 Avg. volume 11,686,104
50-day MA $3.30 Dividend yield N/A
200-day MA $4.04 Market Cap 1.55B

GERN Stock Price Chart Interactive Chart >


Geron Corporation (GERN) Company Bio


Geron Corporation focuses on the development of telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California.


GERN Latest News Stream


Event/Time News Detail
Loading, please wait...

GERN Latest Social Stream


Loading social stream, please wait...

View Full GERN Social Stream

GERN Price Returns

1-mo -11.42%
3-mo -32.28%
6-mo -44.59%
1-year 27.36%
3-year 148.54%
5-year 95.42%
YTD -27.68%
2024 67.77%
2023 -12.81%
2022 98.36%
2021 -23.27%
2020 16.91%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!